Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4flp | JQ1 | Bromodomain testis-specific protein |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4flp | JQ1 | Bromodomain testis-specific protein | / | 1.000 | |
| 4uyg | 73B | Bromodomain-containing protein 2 | / | 0.617 | |
| 4a9o | A9O | Bromodomain-containing protein 2 | / | 0.600 | |
| 4alh | A9P | Bromodomain-containing protein 2 | / | 0.575 | |
| 4ogi | R78 | Bromodomain-containing protein 4 | / | 0.570 | |
| 4mr6 | 1K0 | Bromodomain-containing protein 2 | / | 0.567 | |
| 4c67 | L5S | Bromodomain-containing protein 4 | / | 0.566 | |
| 4a9n | A9N | Bromodomain-containing protein 2 | / | 0.564 | |
| 4j0s | 1H3 | Bromodomain-containing protein 4 | / | 0.561 | |
| 4uyf | 73B | Bromodomain-containing protein 2 | / | 0.560 | |
| 4hxs | 1A3 | Bromodomain-containing protein 4 | / | 0.550 | |
| 4lrg | 1XB | Bromodomain-containing protein 4 | / | 0.550 | |
| 4men | 25K | Bromodomain-containing protein 4 | / | 0.550 | |
| 4akn | S5B | Bromodomain-containing protein 2 | / | 0.549 | |
| 4nr5 | 2LL | CREB-binding protein | / | 0.548 | |
| 4o71 | CPB | Bromodomain-containing protein 4 | / | 0.548 | |
| 5bt5 | 2LO | Bromodomain-containing protein 2 | / | 0.548 | |
| 4bjx | 73B | Bromodomain-containing protein 4 | / | 0.545 | |
| 4mr4 | 1K0 | Bromodomain-containing protein 4 | / | 0.541 | |
| 4qzs | JQ1 | Bromodomain-containing protein 4 | / | 0.541 | |
| 4c66 | H4C | Bromodomain-containing protein 4 | / | 0.540 | |
| 4j0r | 1H2 | Bromodomain-containing protein 4 | / | 0.540 | |
| 2yem | WSH | Bromodomain-containing protein 4 | / | 0.539 | |
| 4bw2 | UTH | Bromodomain-containing protein 4 | / | 0.535 | |
| 4bw3 | 9BM | Bromodomain-containing protein 4 | / | 0.533 | |
| 4a9l | P9L | Bromodomain-containing protein 4 | / | 0.529 | |
| 4hxn | 1A7 | Bromodomain-containing protein 4 | / | 0.525 | |
| 4lr6 | 1XA | Bromodomain-containing protein 4 | / | 0.525 | |
| 2ydw | WSH | Bromodomain-containing protein 2 | / | 0.524 | |
| 4nqm | Y1Z | Bromodomain-containing protein 4 | / | 0.521 | |
| 3aqa | BYH | Bromodomain-containing protein 2 | / | 0.519 | |
| 4hby | 13F | Bromodomain-containing protein 4 | / | 0.518 | |
| 4hxr | 1A4 | Bromodomain-containing protein 4 | / | 0.517 | |
| 4meq | 25O | Bromodomain-containing protein 4 | / | 0.517 | |
| 2yek | EAM | Bromodomain-containing protein 2 | / | 0.514 | |
| 4hxo | 1A6 | Bromodomain-containing protein 4 | / | 0.513 | |
| 4o74 | R78 | Bromodomain-containing protein 4 | / | 0.513 | |
| 2yel | WSH | Bromodomain-containing protein 4 | / | 0.508 | |
| 4f3i | 0S6 | Bromodomain-containing protein 4 | / | 0.506 | |
| 4py6 | R78 | Bromodomain protein, putative | / | 0.504 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.502 | |
| 4bw1 | S5B | Bromodomain-containing protein 4 | / | 0.499 | |
| 4mr5 | 1K0 | Bromodomain-containing protein 2 | / | 0.497 | |
| 3zyu | 1GH | Bromodomain-containing protein 4 | / | 0.491 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.487 | |
| 4j1p | 1K0 | Bromodomain-containing protein 2 | / | 0.484 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.484 | |
| 4lyw | 21Q | Bromodomain-containing protein 4 | / | 0.480 | |
| 4hbw | 14Z | Bromodomain-containing protein 4 | / | 0.479 | |
| 3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.476 | |
| 4alg | 1GH | Bromodomain-containing protein 2 | / | 0.476 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.476 | |
| 2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.475 | |
| 4mep | 24Y | Bromodomain-containing protein 4 | / | 0.475 | |
| 5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.474 | |
| 4o78 | SAV | Bromodomain-containing protein 4 | / | 0.473 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.472 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.471 | |
| 1beu | IPL | Tryptophan synthase alpha chain | / | 0.469 | |
| 2cib | CM6 | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.468 | |
| 4kne | 1CY | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.467 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.467 | |
| 2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.467 | |
| 4j3i | 1K0 | Bromodomain-containing protein 4 | / | 0.467 | |
| 4awp | 99A | Heat shock protein HSP 90-alpha | / | 0.466 | |
| 1j3j | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.465 | |
| 1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.465 | |
| 2v5a | LZL | Biotin carboxylase | 6.3.4.14 | 0.464 | |
| 4ead | 0NP | Thymidine phosphorylase | 2.4.2.4 | 0.464 | |
| 1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
| 4ir5 | IR5 | Bromodomain adjacent to zinc finger domain protein 2B | / | 0.462 | |
| 4trn | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
| 2w3v | TOP | Dihydrofolate reductase | / | 0.459 | |
| 3pqb | VGP | Putative oxidoreductase | / | 0.459 | |
| 4cfl | 8DQ | Bromodomain-containing protein 4 | / | 0.459 | |
| 4egn | TWO | Cytochrome P450 | / | 0.459 | |
| 4fhi | 0S4 | Vitamin D3 receptor A | / | 0.459 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 4dc0 | NDP | Putative ketoacyl reductase | 1.3.1 | 0.458 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.457 | |
| 3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.456 | |
| 3cgd | COA | Coenzyme A disulfide reductase | / | 0.456 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.456 | |
| 1eny | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.455 | |
| 4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.455 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.455 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
| 1nvt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.454 | |
| 1s19 | MC9 | Vitamin D3 receptor | / | 0.454 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.454 | |
| 4mv8 | ACP | Biotin carboxylase | 6.3.4.14 | 0.454 | |
| 4yek | THM | Thymidine phosphorylase | / | 0.454 | |
| 3sn6 | P0G | Beta-2 adrenergic receptor | / | 0.454 | |
| 2qbm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.453 | |
| 4bw4 | 9B6 | Bromodomain-containing protein 4 | / | 0.453 | |
| 4h6r | FDA | Proline dehydrogenase | / | 0.453 | |
| 5ii2 | LU2 | Protein polybromo-1 | / | 0.453 | |
| 1ykd | CMP | Adenylate cyclase | / | 0.452 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.452 | |
| 3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.452 | |
| 3zw9 | NAD | Peroxisomal bifunctional enzyme | 1.1.1.35 | 0.452 | |
| 4l8u | 9AZ | Serum albumin | / | 0.452 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.451 | |
| 2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
| 3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.451 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.451 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.451 | |
| 4zju | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.451 | |
| 2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.450 | |
| 3t3q | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.450 | |
| 4hw2 | 19H | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.450 | |
| 1dna | CB3 | Thymidylate synthase | / | 0.449 | |
| 1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.449 | |
| 2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 3tw6 | ADP | Pyruvate carboxylase | / | 0.449 | |
| 4l4d | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 1m9m | 6NI | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.448 | |
| 1rkh | VD2 | Vitamin D3 receptor | / | 0.448 | |
| 2fgk | ATP | Alpha-hemolysin translocation ATP-binding protein HlyB | / | 0.448 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.448 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.448 | |
| 4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.448 | |
| 4awo | 99B | Heat shock protein HSP 90-alpha | / | 0.448 | |
| 4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.448 | |
| 1rdt | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 2oax | SNL | Mineralocorticoid receptor | / | 0.447 | |
| 3ict | ADP | Coenzyme A disulfide reductase | / | 0.447 | |
| 3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.447 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 4g1z | 0VP | Vitamin D3 receptor A | / | 0.447 | |
| 4gpj | 0Q1 | Bromodomain-containing protein 4 | / | 0.447 | |
| 4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1ie8 | KH1 | Vitamin D3 receptor | / | 0.446 | |
| 2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.446 | |
| 3dva | TPW | Pyruvate dehydrogenase E1 component subunit alpha | 1.2.4.1 | 0.446 | |
| 3dva | TPW | Pyruvate dehydrogenase E1 component subunit beta | 1.2.4.1 | 0.446 | |
| 3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.446 | |
| 4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.446 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.446 | |
| 1ppj | ANY | Cytochrome b | / | 0.445 | |
| 1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.445 | |
| 4c0b | ATP | mRNA cleavage and polyadenylation factor CLP1 | / | 0.445 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.445 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 2acw | UPG | Glycosyltransferase | / | 0.444 | |
| 2hb7 | O1C | Vitamin D3 receptor | / | 0.444 | |
| 2hk9 | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.444 | |
| 2idz | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
| 2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.444 | |
| 3vtd | TKD | Vitamin D3 receptor | / | 0.444 | |
| 4fgg | 0U5 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 4ite | TEY | Vitamin D3 receptor | / | 0.444 | |
| 4zm6 | ACO | N-acetyl-beta-D glucosaminidase | / | 0.444 | |
| 5ccc | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1fmj | RTL | Retinol dehydratase | / | 0.443 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.443 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.443 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
| 3gob | HXX | DdmC | / | 0.443 | |
| 3i1f | GCP | Translation initiation factor 2 subunit gamma | / | 0.443 | |
| 3pm1 | ET | HTH-type transcriptional regulator QacR | / | 0.443 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 2c31 | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.442 | |
| 2h9i | EAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
| 3c6u | M22 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
| 3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 3glm | COO | Glutaconyl-CoA decarboxylase alpha subunit | / | 0.442 | |
| 3ii4 | 3II | Dihydrolipoyl dehydrogenase | 1.8.1.4 | 0.442 | |
| 3kpz | ZNE | Vitamin D3 receptor | / | 0.442 | |
| 3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 4ruj | VDX | Vitamin D3 receptor A | / | 0.442 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 1txi | TX5 | Vitamin D3 receptor | / | 0.441 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.441 | |
| 2m56 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 2pmd | GNP | Translation initiation factor 2 subunit gamma | / | 0.441 | |
| 2qd3 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.441 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.441 | |
| 3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.441 | |
| 3jun | AKD | Phenazine biosynthesis protein A/B | / | 0.441 | |
| 3lxi | CAM | Cytochrome P450 | / | 0.441 | |
| 3srq | Q19 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.440 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
| 3gwf | NAP | Cyclohexanone monooxygenase | / | 0.440 | |
| 3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.440 | |
| 3jsx | CC2 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.440 |